The AcT Trial: Tenecteplase vs Alteplase for Acute Ischemic Stroke
RebelEM
FEBRUARY 1, 2024
Rezaie, MD (Twitter/X: @srrezaie ) The post The AcT Trial: Tenecteplase vs Alteplase for Acute Ischemic Stroke appeared first on REBEL EM - Emergency Medicine Blog. mg/kg, max 25mg) vs. intravenous alteplase (0.09 mg/kg followed by 0.81 vs Alteplase 34.8% Unadjusted risk difference 2.1% [ 95% CI -2.6 mg/kg followed by 0.81 vs Alteplase 34.8%
Let's personalize your content